These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 35036081)
1. Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma. Zhong T; Jiang Z; Wang X; Wang H; Song M; Chen W; Yang S PeerJ; 2022; 10():e12493. PubMed ID: 35036081 [TBL] [Abstract][Full Text] [Related]
2. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis. Xu Y; Kong D; Li Z; Qian L; Li J; Zou C PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma. Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636 [TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma. Miao S; Song J; Liu Q; Lai J; Wang H; Ran L Med Oncol; 2022 Jun; 39(9):128. PubMed ID: 35716215 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC). Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404 [TBL] [Abstract][Full Text] [Related]
6. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis. Sui Y; Lu K; Fu L PeerJ; 2021; 9():e11272. PubMed ID: 33976979 [TBL] [Abstract][Full Text] [Related]
7. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis. Wang S; Yu ZH; Chai KQ Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194 [TBL] [Abstract][Full Text] [Related]
8. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363 [TBL] [Abstract][Full Text] [Related]
9. Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma. Gao S; Yan L; Zhang H; Fan X; Jiao X; Shao F Front Genet; 2020; 11():603455. PubMed ID: 33613617 [TBL] [Abstract][Full Text] [Related]
10. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma. Wang J; He X; Mi Y; Chen YQ; Li J; Wang R BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981 [TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma. Wu F; Wu S; Gou X Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586 [TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis. Zhang N; Chen W; Gan Z; Abudurexiti A; Hu X; Sang W Medicine (Baltimore); 2020 May; 99(21):e20470. PubMed ID: 32481352 [TBL] [Abstract][Full Text] [Related]
13. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578 [TBL] [Abstract][Full Text] [Related]
14. NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma. Zheng B; Wang S; Yuan X; Zhang J; Shen Z; Ge C BMC Urol; 2023 May; 23(1):82. PubMed ID: 37138262 [TBL] [Abstract][Full Text] [Related]
15. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets. Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280 [TBL] [Abstract][Full Text] [Related]
16. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma. Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma. Zhu Z; He A; Lv T; Xu C; Lin L; Lin J Cancer Biomark; 2019; 26(4):431-439. PubMed ID: 31640086 [TBL] [Abstract][Full Text] [Related]
18. Identification of Prognostic Related Hub Genes in Clear-Cell Renal Cell Carcinoma Jiang P; Sun TT; Chen CW; Huang RS; Zhong ZM; Lou XJ; Liu G; Wang L; Zuo RH Chin Med Sci J; 2021 Jun; 36(2):127-134. PubMed ID: 34231461 [TBL] [Abstract][Full Text] [Related]
19. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma. Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048 [TBL] [Abstract][Full Text] [Related]
20. Identification of TYROBP and FCER1G as Key Genes with Prognostic Value in Clear Cell Renal Cell Carcinoma by Bioinformatics Analysis. Wang L; Lin Y; Yuan Y; Liu F; Sun K Biochem Genet; 2021 Oct; 59(5):1278-1294. PubMed ID: 33786672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]